GlycA Levels during the Earliest Stages of Rheumatoid Arthritis: Potential Use as a Biomarker of Subclinical Cardiovascular Disease

This study aimed at evaluating the clinical relevance of glycoprotein profiles during the earliest phases of rheumatoid arthritis (RA) as biomarkers of cardiovascular (CV) risk and treatment response. Then, GlycA and GlycB serum levels were measured using 1H-nuclear magnetic resonance in 82 early RA...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Carrio, Javier, Alperi-López, Mercedes, López, Patricia, Pérez-Álvarez, Ángel I., Gil-Serret, Miriam, Amigó, Núria, Ulloa, Catalina, Benavente, Lorena, Ballina-García, Francisco J., Suárez, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463667/
https://www.ncbi.nlm.nih.gov/pubmed/32752190
http://dx.doi.org/10.3390/jcm9082472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463667/
https://www.ncbi.nlm.nih.gov/pubmed/32752190
http://dx.doi.org/10.3390/jcm9082472

Ejemplares similares